by dividef | Mar 14, 2023
Mike Varney is the former Executive Vice President and Head of Genentech Research and Early Development (gRED), where he was responsible for all aspects of drug discovery and development for the US based R&D organization in Roche and served as a member of the...
by dividef | Mar 14, 2023
Jim Tananbaum is the founder and CEO of Foresite Capital, a US-focused healthcare investment firm with $3 billion under management. Jim has been a lead financier and thought partner for some of the most impactful and fastest growth companies of their generation...
by dividef | Mar 14, 2023
Zach Sweeney is the CEO at Interline Therapeutics, an Affiliate at ARCH Venture Partners and a Venture Partner at Foresite Labs. He has broad experience growing and leading successful multifunctional drug discovery groups, including small molecule, biotherapeutic, and...
by dividef | Mar 14, 2023
Jay Parrish, Ph.D. is a Venture Partner at ARCH Venture Partners, Chairman of Pretzel Therapeutics, and co-founder and board member of Rome Therapeutics. Previously, he was co-founder and Chief Business Officer of Vir Biotechnology, a company focused on infectious...
by dividef | Mar 14, 2023
Kristina Burow is focused on the creation and development of biotechnology, pharmaceutical and health tech companies. Since joining ARCH in 2002, she has risen from Associate to Managing Director and has played a significant role in the growth of ARCH’s life sciences...
Recent Comments